DDAVP and Oxybutynin Extended-Release Tablets
Determining the interaction of DDAVP and Oxybutynin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: desmopressin
Brand name: DDAVP, Nocdurna, DDAVP nasal, DDAVP Rhinal Tube, Noctiva, Stimate
Synonyms: DDAVP (injection)
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- DDAVP-Oxybutynin Gel
- DDAVP-Oxybutynin Oral Solution
- DDAVP-Oxybutynin Syrup
- DDAVP-Oxybutynin Tablets
- DDAVP-Oxybutynin transdermal
- DDAVP-Oxybutynin Transdermal System
- Oxybutynin Extended-Release Tablets-DDAVP (Desmopressin Injection Solution)
- Oxybutynin Extended-Release Tablets-DDAVP (Desmopressin Nasal Spray (Diabetes Insipidus))
- Oxybutynin Extended-Release Tablets-DDAVP (Desmopressin Tablets)
- Oxybutynin Extended-Release Tablets-DDAVP injection
- Oxybutynin Extended-Release Tablets-DDAVP nasal
- Oxybutynin Extended-Release Tablets-DDAVP Nasal Spray